Arch Therapeutics CEO looks ahead to positive results on AC5 gel

Arch Therapeutics (OTCMKTS:ARTH, OTCQB:ARTH) CEO Dr. Terry Norchie tells Proactive Investors the biotechnology company is …
(Orginal – Story lesen…)